Dileep Kumar

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Skeletal Muscle

Respiratory Syndrome Coronavirus

Papillary Thyroid

Top Venues

Drug metabolism and personalized therapy

Current molecular pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Dipanjan Karati, Dileep Kumar
Molecular Insight into the Apoptotic Mechanism of Cancer Cells: An Explicative Review. Current molecular pharmacology 17 (2024)
Saurabh G Londhe, Mangala Shenoy, Suvarna G Kini, Vinayak Walhekar, Dileep Kumar
Computational Investigation of Novel Compounds as Dual Inhibitors of AChE and GSK-3β for the Treatment of Alzheimer's Disease. Current topics in medicinal chemistry (2024)
Dipanjan Karati, Dileep Kumar
Molecular Insight into the Apoptotic Mechanism of Cancer Cells: An Explicative Review. Current molecular pharmacology 17 (2024)
Siddhant Tripathi, Yashika Sharma, Rajesh Rane, Dileep Kumar
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment. CNS & neurological disorders drug targets (2024)
Saurabh G Londhe, Vinayak Walhekar, Shenoy K Mangala, Suvarna G Kini, Marcus Tullius Scotti, Luciana Scotti, Dileep Kumar
Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease. Pharmaceutics 16 (8) (2024)
Saurabh G Londhe, Vinayak Walhekar, Shenoy K Mangala, Suvarna G Kini, Marcus Tullius Scotti, Luciana Scotti, Dileep Kumar
Computational and ADMET Predictions of Novel Compounds as Dual Inhibitors of BuChE and GSK-3β to Combat Alzheimer's Disease. Pharmaceutics 16 (8) (2024)
Dipanjan Karati, Dileep Kumar
An Insight into Synthetic Strategies, SAR Study and Anticancer Mechanism of Chalcone Derivatives: Medicinal Chemistry Perspective. Current drug research reviews (2024)
Ryan Varghese, Pal Patel, Dileep Kumar, Rohit Sharma
Climate change and glacier melting: risks for unusual outbreaks? Journal of travel medicine (2023)
Ryan Varghese, Dileep Kumar, Rohit Sharma
Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern? Human cell (2023)
Ryan Varghese, Pal Patel, Dileep Kumar, Rohit Sharma
Monkeypox and drug repurposing: seven potential antivirals to combat the viral disease. Reviews on environmental health (2023)
Ryan Varghese, Dileep Kumar, Rohit Sharma
Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern? Human cell (2023)
Ryan Varghese, Dileep Kumar, Rohit Sharma
Global threat from novel SARS-CoV-2 variants, BF.7, XBB.1.5, BQ.1, and BQ.1.1: variants of concern? Human cell (2023)
Dipanjan Karati, Dileep Kumar
A Comprehensive Review on Targeted Cancer Therapy: New Face of Treatment Approach. Current pharmaceutical design (2023)
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug metabolism and personalized therapy (2023)
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease. Molecular neurobiology (2023)
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug metabolism and personalized therapy 38 (4) (2023)
Ryan Varghese, Gargi Digholkar, Jainam Karsiya, Sahil Salvi, Jeenam Shah, Dileep Kumar, Rohit Sharma
PDE5 inhibitors: breaking new grounds in the treatment of COVID-19. Drug metabolism and personalized therapy 38 (4) (2023)
Ryan Varghese, Sanidhya Pai, Dileep Kumar, Rohit Sharma
SARS-CoV-2 XBB.1.16 variant: India in focus? Journal of medical virology 95 (5) (2023)
Dipanjan Karati, Ryan Varghese, K R Mahadik, Rohit Sharma, Dileep Kumar
Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Iqrar Ahmad Ansari, Dileep Kumar, Harun M Patel
Computational investigation of phytochemicals from Withania somnifera (Indian ginseng/ashwagandha) as plausible inhibitors of GluN2B-containing NMDA receptors. Journal of biomolecular structure & dynamics (2021)